Literature DB >> 2163771

Preferential usage of the V beta 8 gene family by CD4-CD8-T cell lines derived from spleen.

H C O'Neill1.   

Abstract

Receptors encoded by the V beta 8 gene family and identified by the F23.1 antibody are commonly expressed amongst the CD4-CD8-T cell lines isolated from spleen cells infected in vitro with the RadLV retrovirus. All but one out of 12 cell lines showed between 50 and 85% F23.1+ cells in the uncloned cell population which is noticably higher than the approximately 13% level amongst the Ig- normal spleen cell population. There was a high frequency (approximately 50%) of F23.1+ clones from five of these cell lines. The frequency of F23.1 binding cells in the Ig-, CD4/CD8-depleted spleen population is only 0.2%, which gives a precursor frequency in spleen of less than 0.002%. This reflects selective isolation of CD4-CD8- alpha beta+ cells which express V beta 8 gene products by this culture scheme. The requirement for RadLV in induction of these cell lines has been established, suggesting that this retrovirus may selectively stimulate CD4-CD8-F23.1+ T cells. These cells may represent an autoimmune subset present in peripheral lymphoid tissue.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2163771     DOI: 10.1016/0008-8749(90)90202-3

Source DB:  PubMed          Journal:  Cell Immunol        ISSN: 0008-8749            Impact factor:   4.868


  3 in total

1.  A murine retrovirus induces proliferation of unique lymphoid cell lines expressing T-cell-receptor structures utilizing common variable region alpha and beta chain genes.

Authors:  H C O'Neill
Journal:  Proc Natl Acad Sci U S A       Date:  1993-04-01       Impact factor: 11.205

2.  Germline transcription and expression of Tcrb-V8 genes in peripheral mouse lymphoid tissues.

Authors:  H C O'Neill; C J Jolly
Journal:  Immunogenetics       Date:  1995       Impact factor: 2.846

3.  Adoptive transfer of polyclonal and cloned cytolytic T lymphocytes (CTL) specific for mouse AIDS-associated tumors is effective in preserving CTL responses: a measure of protection against LP-BM5 retrovirus-induced immunodeficiency.

Authors:  W R Green; K A Green; K M Crassi
Journal:  J Virol       Date:  1994-07       Impact factor: 5.103

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.